Let-rozole IP

Let-rozole IP Specification

Structural Formula
C H N

Particle Size
4.77 m

Molecular Weight
285.303 GSM (gm/2)

Molecular Formula
C H N

Heavy Metal (%)
Less than 10 ppm

Solubility
Freely soluble in Dichloromethane, slightly soluble in alcohol, Insoluble in water.

Medicine Name
Letrozole IP

Chemical Name
Letrozole IP

CAS No
112809-51-5

Type
Pharmaceutical Intermediates

Grade
Other

Usage
Letrozole is commonly prescribed as adjuvant therapy, extended adjuvant therapy, or for advanced and metastatic breast cancer, and is also used off-label for ovulation induction in infertility treatment.

Purity(%)
99.58 %

Appearance
White crystalline powder

Physical Form
Powder

Let-rozole IP Trade Information

Minimum Order Quantity
1 Kilograms

Delivery Time
1 Week

About Let-rozole IP

Letrozole is a non-steroidal aromatase inhibitor used primarily in the treatment of hormone-dependent breast cancer in postmenopausal women. It works by selectively inhibiting the aromatase enzyme, thereby reducing estrogen synthesis in peripheral tissues and limiting the growth of estrogen-sensitive tumors. Letrozole is commonly prescribed as adjuvant therapy, extended adjuvant therapy, or for advanced and metastatic breast cancer, and is also used off-label for ovulation induction in infertility treatment. Owing to its high potency, oral bioavailability, and favorable clinical outcomes, letrozole is an important drug in endocrine therapy. Synonyms: Femara, CGS-20267, Letrozol, Letrozolum.